Capital Research owns 9.59M XPO shares (8.2%)
XPO, Inc. registers that Capital Research Global Investors reports beneficial ownership of 9,588,191 shares of XPO common stock, representing 8.2% of the 117,147,357 shares believed outstanding as of 03/31/2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
XPO, Inc. registers that Capital Research Global Investors reports beneficial ownership of 9,588,191 shares of XPO common stock, representing 8.2% of the 117,147,357 shares believed outstanding as of 03/31/2026. The filing shows sole voting power over 9,562,249 shares and sole dispositive power over 9,588,191 shares. The amendment is signed by a Capital Research officer on 05/11/2026.
Insights
Capital Research holds a material passive stake in XPO at 8.2%.
Capital Research Global Investors reports beneficial ownership of 9,588,191 shares, equal to 8.2% of the company's 117,147,357 shares believed outstanding as of 03/31/2026. The filing lists sole voting power of 9,562,249 shares, indicating near-full control of its position.
Holdings at this scale can appear in proxy and engagement contexts; subsequent disclosures or transactions would clarify any active intentions. Future amendments would show changes in percent or disposition.
This is an amended Schedule 13G filing updating ownership disclosures.
The amendment identifies Capital Research Global Investors and affiliated investment management entities as the record contributors to the reported position, and it uses the Schedule 13G/A form's passive-investor framework. The statement attributes beneficial ownership across affiliated entities.
Filing mechanics: the document is signed and dated 05/11/2026. Any change to voting or disposition authority must be reported via further amendments per regulatory rules.
Key Figures
Key Terms
beneficially owned regulatory
sole voting power regulatory
sole dispositive power regulatory
Schedule 13G/A regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Capital Research Global Investors hold in XPO?
How much voting power does Capital Research report for XPO?
Is this a new filing or an amendment for XPO (XPO)?
Who signed the amended Schedule 13G/A for XPO?
AI-generated analysis. How Rhea-AI works. Not financial advice.